Pharmaceutical

Business Wire IndiaMasimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Anesthesia in which Dr. Yu Jeong Bang and colleagues at the Samsung Medical Center, Sungkyunkwan University School of Medicine, in Seoul, South Korea, investigated the association of Masimo ORi™ and the arterial partial pressure of oxygen (PaO2) […]

Business Wire India Collaboration leverages the proven development and commercial capability of Ferring with PharmaBiome’s compelling technology to research, develop and manufacture novel donor-independent microbiome-based therapies Deal provides access for Ferring to the next generation of microbiome-based therapies, building on Ferring's long term commitment in microbiome drug development ​​ Ferring Pharmaceuticals and Zürich-based microbiome translation […]

Business Wire IndiaIn a significant development, PNB VESPER, a research-based biopharmaceutical company headquartered in Kochi, Kerala has signed agreements with the National Institute on Drug Abuse (NIDA), under NIH USA, the lead federal agency supporting scientific research on drug abuse and addiction disorders, to develop drugs for opioid and cocaine addiction disorders. As per the […]

Business Wire IndiaMary Kay Inc., the world's No. 1 direct selling skin care and color cosmetics brand1 and its company-sponsored foundations, including the Mary Kay Ash Foundation in the U.S., continue to provide unwavering support to women’s cancer research through funding a variety of research programs and projects, awarding grants to world renowned scientists, and […]

Business Wire IndiaAOP Orphan Pharmaceuticals GmbH (AOP Health), Vienna, Austria, announced the results of an analysis assessing the impact of an individually optimized dosing regimen of ropeginterferon alfa-2b on treatment response in patients with low-risk polycythaemia vera (PV)1 These new data show that some low-risk PV patients require and can tolerate high ropeginterferon alfa-2b doses, […]